Non-replicating expression vectors: applications in vaccine development and gene therapy.
Limbach
K J
KJ
Virogenetics Corporation, Rensselaer Technology Park, Troy, New York 12180, USA.
Paoletti
E
E
D000256:Adenoviridae; D000818:Animals; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy; D011212:Poxviridae; D012190:Retroviridae; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000627:therapeutic use*; D014777:Virus Diseases / Q000235:genetics / Q000628:therapy*
D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines